Navigation LinksTop Biology NewsTop Medical NewsTop Biology TechnologyTop Medical Technology


FDA Panel Backs At-Home HIV Test

5/16/2012
By Randy Dotinga HealthDay Reporter TUESDAY, May 15 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel recommended Tuesday approval of the first HIV test that would give people the results in the privacy of their own home. The 17 panel members were unani... [Comments]FDA Panel Backs At-Home HIV Test

Education Is Key to Health: Report

5/16/2012
By Steven Reinberg HealthDay Reporter WEDNESDAY, May 16 (HealthDay News) -- The better educated you are and the more money you make, the healthier you're likely to be, a U.S. government report released Wednesday shows. The report found that more educated people with higher in... [Comments]Education Is Key to Health: Report

Urban Hospitals May Act as Breeding Ground for MRSA

5/16/2012
WEDNESDAY, May 16 (HealthDay News) -- A dangerous antibiotic-resistant "superbug" appears to originate in hospitals in large cities and then spreads to smaller hospitals, according to a new study. Researchers at the University of Edinburgh in Scotland analyzed the genetic ma... [Comments]Urban Hospitals May Act as Breeding Ground for MRSA

Developmental Woes Common in Siblings of Children With Autism

5/16/2012
WEDNESDAY, May 16 (HealthDay News) -- One in three children with an older sibling who has an autism spectrum disorder, or problems with social interaction and communication, shows signs of developmental delay or autism-related behaviors by the age of 3 years, according to a new... [Comments]Developmental Woes Common in Siblings of Children With Autism 

Many Parents of Kids With Autism Don't Put Faith in Pediatricians

5/16/2012
By Jenifer Goodwin HealthDay Reporter WEDNESDAY, May 16 (HealthDay News) -- Many parents of children with an autism spectrum disorder don't feel they can turn to their pediatricians for advice on treatments, a new study finds. Likewise, many pediatricians don't think they hav... [Comments]Many Parents of Kids With Autism Don't Put Faith in Pediatricians

Researchers make promising discovery in pursuit of effective lymphoma treatments

5/16/2012
NEW YORK, May 16, 2012 Researchers at NYU School of Medicine have identified a target for slowing the progression of multiple myeloma by using currently available drugs. Published recently in Nature Cell Biology , the study reveals a pathway that, if deactivated, may help slow the development of the disease. "We have the ability to target this pathway with drugs that already exist,... [Comments]

Ben-Gurion U. and Cincinnati Children's Hospital to develop pediatric-specific medical technologies

5/16/2012
NEW YORK, May 16, 2012 -- A collaboration to address the lack of medical devices designed specifically for children is being launched by Cincinnati Children's Hospital Medical Center (CCH) in Ohio and Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel. The goal is to improve health outcomes for children by ensuring device design that is customized to meet childrens' unique physiolog... [Comments]

Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards

5/16/2012
LONDON, ON A scientist at Lawson Health Research Institute has been honored in Pfizer Canada's first-ever Psychiatry Research Awards Program. Dr. Elizabeth Osuch, Scientist and Rea Research Chair of Affective and Anxiety Disorders at Lawson, is one of two researchers to receive $100,000 to support their research. Dr. Osuch's winning proposal aims to improve diagnosis of bipolar disorder i... [Comments]

Humanist funerals

5/16/2012
Funeral directors need to be aware of the needs of non-religious people. A unique investigation into the subject funded by the Economic and Social Research Council (ESRC) provides a snapshot of a defining aspect of life - or indeed death. "The issue of death is one of the most important incidents that all societies deal with," says Dr Matthew Engelke, at the London School of Economics. "I... [Comments]

Life-saving primary PCI rising in Stent for Life countries

5/16/2012
Paris, 16 May 2012: Life saving primary percutaneous coronary intervention (PPCI) treatment is increasing in countries participating in the Stent for Life Initiative. These achievements and other activities will be revealed at EuroPCR 2012 , 15-18 May, in Paris, France. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI... [Comments]

[next]
(Date:5/15/2012)... May 15 (HealthDay News) -- "Team-based care" should be ... Task Force on Community Preventive Services recommended on Tuesday. ... 77 studies that showed improvements in patients, control of ... of health professionals -- a primary care doctor supported ... health worker -- rather than a primary care doctor ...
(Date:5/15/2012)... DETROIT Patients who undergo radical surgery for ... if they,re treated in accredited teaching hospitals with ... also have medical fellowships, according to a new ... which evaluated postoperative complications in 47,100 radical prostatectomy ... those with fewer complications after the surgery were ...
(Date:5/15/2012)... undergo one of the most common treatments for prostate ... to new research by Henry Ford Hospital. , In ... of the surgeon doing the procedure mattered somewhat less ... data gathered throughout the U.S., will be presented this ... Atlanta. , It is both intuitive "practice makes ...
(Date:5/15/2012)... than men after surgical removal of part or all ... dying in the hospital, although they are more likely ... , But Henry Ford Hospital researchers who documented these ... results of the new study, based on population samples ... at the American Urological Association,s Annual Meeting in Atlanta. ...
(Date:5/15/2012)... a team of Rice University freshmen took a mousetrap ... children in the developing world. , "The goal was ... so we could prevent over-hydration and under-hydration," said Melissa ... in Pediatrics) team and a mechanical engineering major. "It,s ... the world, where conditions can be pretty primitive and ...
Breaking Medicine News(10 mins):Health News:U.S. Task Force Issues Blood Pressure Guidelines 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2Health News:Women fare better than men, but need more blood after kidney cancer surgery 2Health News:Women fare better than men, but need more blood after kidney cancer surgery 3Health News:This 'mousetrap' may save lives 2
... 8 Allscripts-Misys Healthcare,Solutions, Inc., formerly Allscripts Healthcare ... financial results for the three and six,months ended ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ) , ... six months ended November 30, 2008,include results from ...
... International, Inc.,(Nasdaq: CHDX ) ("CHDX" or "the ... and services in the People,s Republic,of China, today announced ... Conference, to be held in Shanghai on January 12th ... UBS Greater China Conference will be held at the ...
... be used when assessing traditional risk factors, experts say , , ... or "biomarkers" -- of inflammation may provide useful information when ... says. , "If you are very high or very low ... study lead author Dr. Vijay Nambi, a cardiologist at the ...
... Company,s Email Encryption business continues to drive overall performanceDALLAS, ... ZIXI ), the leader in hosted services for email ... its chief executive officer, Rick Spurr."We ended the year ... as we booked the highest orders for the year ...
... A proposal by the State of Indiana to close ... the 125,000-member American Legion Department of Indiana to revamp ... to organize and coordinate its members, nearly unanimous opposition ... $50,000 in direct and in-kind support to the home, ...
... YORK, Jan. 8 United Jewish Communities (UJC) and ... raise $10 million to address humanitarian and social needs ... support and stand in solidarity with Israelis during the ... of the Gaza Strip. The funds will enhance programs ...
Other Medicine News:Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ... size and angle required for large and ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
Medicine Products:
(Date:5/16/2012)...  Reportlinker.com announces that a new market ... Global Human Vaccines ... http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and _ This report ... Vaccines in US$ Million by the following ... Prophylactic Vaccines. The report provides separate comprehensive ...
(Date:5/16/2012)...  NuMe Health LLC, a biotechnology company developing ... live in the gastrointestinal (GI) tract to support ... closed a $1.5 million Series A financing.  NuMe ... clinical trial of its lead cobiotic product, NM504, ... to support maintenance of healthy blood glucose levels ...
(Date:5/15/2012)... 2012  Nephros, Inc. (OTC Bulletin Board: ... developing and marketing filtration products for therapeutic applications, ... results for the three months ended March 31, ... , Received FDA 510(k) clearance to market hemodiafiltration ... and supply agreement with Medica S.p.A. , ...
Breaking Medicine Technology:Global Human Vaccines Industry 2Global Human Vaccines Industry 3Global Human Vaccines Industry 4Global Human Vaccines Industry 5Global Human Vaccines Industry 6Global Human Vaccines Industry 7Global Human Vaccines Industry 8Global Human Vaccines Industry 9Global Human Vaccines Industry 10Global Human Vaccines Industry 11Global Human Vaccines Industry 12Global Human Vaccines Industry 13Global Human Vaccines Industry 14Global Human Vaccines Industry 15Global Human Vaccines Industry 16Global Human Vaccines Industry 17Global Human Vaccines Industry 18Global Human Vaccines Industry 19Global Human Vaccines Industry 20Global Human Vaccines Industry 21Global Human Vaccines Industry 22NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobioticâ„¢ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels 2NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobioticâ„¢ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels 3Nephros Reports First Quarter 2012 Financial Results 2Nephros Reports First Quarter 2012 Financial Results 3Nephros Reports First Quarter 2012 Financial Results 4Nephros Reports First Quarter 2012 Financial Results 5Nephros Reports First Quarter 2012 Financial Results 6Nephros Reports First Quarter 2012 Financial Results 7Nephros Reports First Quarter 2012 Financial Results 8Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 1Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 2Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 3Stem cells shape up to their surroundings 15787 1Stem cells shape up to their surroundings 15787 2Stem cells shape up to their surroundings 15787 3Redpoint Advances Salt Enhancer Discovery Program 17542 1Redpoint Advances Salt Enhancer Discovery Program 17542 2Redpoint Advances Salt Enhancer Discovery Program 17542 3Redpoint Advances Salt Enhancer Discovery Program 17542 4
... Presented at International Conference on Malignant ... Shows Dose Dependent Single Agent Activity, BETHESDA, ... biopharmaceutical company developing novel, proprietary antibodies,for the treatment ... update of an ongoing phase 1 clinical trial ...
... Discuss Clinical, Financial ... DUBLIN, Ohio, June 4 In a move that ... of,hospital-acquired infections (HAIs), Cardinal Health announced today that,it will ... will focus on the leadership and operational issues that ...
Other Medicine Technology:Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 2Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 3Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 4Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 5Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 2Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 4